| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.54▼ | 3.54▼ | 3.50▲ | 3.46▲ | 3.95▼ |
| MA10 | 3.52▲ | 3.48▲ | 3.57▼ | 3.18▲ | 3.23▲ |
| MA20 | 3.47▲ | 3.61▼ | 3.73▼ | 3.58▼ | 2.25▲ |
| MA50 | 3.71▼ | 3.50▲ | 3.32▲ | 3.34▲ | 2.74▲ |
| MA100 | 3.72▼ | 3.19▲ | 3.25▲ | 2.31▲ | 7.60▼ |
| MA200 | 3.39▲ | 3.52▲ | 4.65▼ | 2.19▲ | 53.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | -0.013▼ | -0.055▼ | -0.024▼ | 0.304▲ |
| RSI | 46.897▼ | 48.131▼ | 50.508▲ | 48.941▼ | 54.838▲ |
| STOCH | 90.786▲ | 77.324 | 20.683 | 61.710 | 26.924 |
| WILL %R | -5.714▲ | -62.500 | -79.375▼ | -41.436 | -86.498▼ |
| CCI | 50.887 | 25.003 | -49.604 | 78.751 | 21.126 |
|
Monday, August 04, 2025 07:05 AM
NYSE:SON Earnings and Revenue History August 4th 2025 How Do Unusual Items Influence Profit? Importantly, our data indicates that Sonoco Products' profit was reduced by US$306m, d ...
|
|
Monday, August 04, 2025 05:49 AM
Sonnet's lead product, SON-1010 (IL12-FHAB), is being evaluated in combination with atezolizumab (Tecentriq®) in patients with advanced platinum-resistant ovarian cancer (PROC) (SB221) Topline safety, ...
|
|
Saturday, July 19, 2025 08:21 AM
Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)’s merger with Rorschach I LLC. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 3.68 | 3.76 | 3.32 | 3.54 | 609,461 |
| 14/08/25 | 3.50 | 4.29 | 3.49 | 3.76 | 1,452,277 |
| 13/08/25 | 3.05 | 4.05 | 3.05 | 3.95 | 3,020,148 |
| 12/08/25 | 3.08 | 3.17 | 2.80 | 2.99 | 363,456 |
| 11/08/25 | 3.39 | 3.5897 | 3.01 | 3.07 | 834,501 |
| 08/08/25 | 2.99 | 3.36 | 2.75 | 3.22 | 755,976 |
| 07/08/25 | 3.07 | 3.18 | 2.83 | 2.88 | 405,967 |
| 06/08/25 | 2.59 | 3.1896 | 2.48 | 2.98 | 802,531 |
| 05/08/25 | 2.75 | 2.94 | 2.58 | 2.65 | 529,570 |
| 04/08/25 | 2.87 | 2.9599 | 2.61 | 2.81 | 880,989 |
|
|
||||
|
|
||||
|
|